123 related articles for article (PubMed ID: 34916429)
1. Impact of alpha-synuclein pathology on adult neurogenesis: evidence for multilayered mechanisms.
Bonsberger J; Richter F; Stanojlovic M
Neural Regen Res; 2022 Jul; 17(7):1491-1492. PubMed ID: 34916429
[No Abstract] [Full Text] [Related]
2. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
3. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J
Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794
[TBL] [Abstract][Full Text] [Related]
4. Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus.
Bender H; Fietz SA; Richter F; Stanojlovic M
Front Cell Dev Biol; 2021; 9():691560. PubMed ID: 34307368
[TBL] [Abstract][Full Text] [Related]
5. Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus.
Winner B; Regensburger M; Schreglmann S; Boyer L; Prots I; Rockenstein E; Mante M; Zhao C; Winkler J; Masliah E; Gage FH
J Neurosci; 2012 Nov; 32(47):16906-16. PubMed ID: 23175842
[TBL] [Abstract][Full Text] [Related]
6. The temporal expression pattern of alpha-synuclein modulates olfactory neurogenesis in transgenic mice.
Schreglmann SR; Regensburger M; Rockenstein E; Masliah E; Xiang W; Winkler J; Winner B
PLoS One; 2015; 10(5):e0126261. PubMed ID: 25961568
[TBL] [Abstract][Full Text] [Related]
7. Human wild-type alpha-synuclein impairs neurogenesis.
Winner B; Lie DC; Rockenstein E; Aigner R; Aigner L; Masliah E; Kuhn HG; Winkler J
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1155-66. PubMed ID: 15581183
[TBL] [Abstract][Full Text] [Related]
8. Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis.
Winner B; Rockenstein E; Lie DC; Aigner R; Mante M; Bogdahn U; Couillard-Despres S; Masliah E; Winkler J
Neurobiol Aging; 2008 Jun; 29(6):913-25. PubMed ID: 17275140
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1.
Desplats P; Spencer B; Crews L; Pathel P; Morvinski-Friedmann D; Kosberg K; Roberts S; Patrick C; Winner B; Winkler J; Masliah E
J Biol Chem; 2012 Sep; 287(38):31691-702. PubMed ID: 22833673
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of voluntary running on cognitive dysfunction in an α-synuclein rat model of Parkinson's disease.
Crowley EK; Nolan YM; Sullivan AM
Neurobiol Aging; 2018 May; 65():60-68. PubMed ID: 29407467
[TBL] [Abstract][Full Text] [Related]
11. Oligomer-prone E57K-mutant alpha-synuclein exacerbates integration deficit of adult hippocampal newborn neurons in transgenic mice.
Regensburger M; Schreglmann SR; Stoll S; Rockenstein E; Loskarn S; Xiang W; Masliah E; Winner B
Brain Struct Funct; 2018 Apr; 223(3):1357-1368. PubMed ID: 29124353
[TBL] [Abstract][Full Text] [Related]
12. Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson's disease.
Desplats P; Patel P; Kosberg K; Mante M; Patrick C; Rockenstein E; Fujita M; Hashimoto M; Masliah E
Mol Neurodegener; 2012 Sep; 7():49. PubMed ID: 23017109
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α-synuclein.
Schlachetzki JC; Grimm T; Schlachetzki Z; Ben Abdallah NM; Ettle B; Vöhringer P; Ferger B; Winner B; Nuber S; Winkler J
J Neurosci Res; 2016 Jan; 94(1):62-73. PubMed ID: 26451750
[TBL] [Abstract][Full Text] [Related]
14. Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Peng J; Andersen JK
Aging Cell; 2011 Apr; 10(2):255-62. PubMed ID: 21108729
[TBL] [Abstract][Full Text] [Related]
15. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
Jellinger KA
Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.
Pavlou MAS; Colombo N; Fuertes-Alvarez S; Nicklas S; Cano LG; Marín MC; Goncalves J; Schwamborn JC
Mol Neurobiol; 2017 Aug; 54(6):4257-4270. PubMed ID: 27339877
[TBL] [Abstract][Full Text] [Related]
17. Cofilin 1 activation prevents the defects in axon elongation and guidance induced by extracellular alpha-synuclein.
Tilve S; Difato F; Chieregatti E
Sci Rep; 2015 Nov; 5():16524. PubMed ID: 26558842
[TBL] [Abstract][Full Text] [Related]
18. Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease.
Yokota O; Davidson Y; Arai T; Hasegawa M; Akiyama H; Ishizu H; Terada S; Sikkink S; Pickering-Brown S; Mann DM
Acta Neuropathol; 2010 Dec; 120(6):789-801. PubMed ID: 20669025
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
20. Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
Breen DP; Halliday GM; Lang AE
Mov Disord; 2019 Mar; 34(3):307-316. PubMed ID: 30653258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
